Skip to content

Dual therapy with Kaletra and 3TC works well regardless of viral load

Pedro Cahn, Fundacion Huesped, Argentina, presents results of the Gardel study at EACS2013. Photo by Liz Highleyman, hivandhepatitis.com

GSK1265744 rapidly suppresses HIV and appears safe at selected dose

David Margolis, Glaxo SmithKline, at EACS 2013. Photo by Liz Highleyman, hivandhepatitis.com

Ensuring good-quality HIV care in Europe: where can we improve?

Professor Jens Lundgren, University of Copenhagen. Photo by Liz Highleyman, hivandhepatitis.com

New EACS treatment guidelines strike balance between individual choice and public health, say writers

New EACS treatment guidelines strike balance between individual choice and public health, say writers

New drugs will bring revolution in hepatitis C treatment

Heiner Wedemeyer, Hannover Medical School, at EACS 2013. Photo by Liz Highleyman, hivandhepatitis.com

CCR5 inhibitor cenicriviroc shows good activity against HIV; new formulation may reduce dropouts

Judith Feinberg of the University of Cincinnati at EACS 2013. Photo by Liz Highleyman / hivandhepatitis.com

Number of people infected with drug-resistant HIV in Europe has risen by around 35%

Anal cancer screening may be appropriate for all women with HIV, French researchers suggest

Thank you Unusual Risks!

Thank you Unusual Risks!